Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review

BACKGROUND: Patients with cancer‐associated venous thromboembolism (VTE) are recommended to receive treatment with therapeutic anticoagulation for at least 3–6 months. Little data exist on extended treatment beyond 6 months. OBJECTIVE: To comprehensively summarize the best available evidence on inci...

Descripción completa

Detalles Bibliográficos
Autores principales: Moik, Florian, Colling, Meaghan, Mahé, Isabelle, Jara‐Palomares, Luis, Pabinger, Ingrid, Ay, Cihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299994/
https://www.ncbi.nlm.nih.gov/pubmed/34816583
http://dx.doi.org/10.1111/jth.15599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299994/
https://www.ncbi.nlm.nih.gov/pubmed/34816583
http://dx.doi.org/10.1111/jth.15599

Ejemplares similares